Prognosis
Gilead Surges After WHO Comments on Virus Drug Testing
A worker wearing a protective suit sprays disinfectant inside a bus at a depot in the Eunpyeong district of Seoul on Feb. 24.
Photographer: SeongJoon Cho/BloombergThis article is for subscribers only.
Gilead Sciences Inc. shares gained Monday after a senior World Health Organization official said the company’s experimental drug may be the best bet to find a treatment for the new coronavirus spreading around the globe.
Gilead’s compound, remdesivir, has been rushed into a clinical trial in China, where the illness has infected tens of thousands of people. WHO officials have said results could be available within weeks.